Bradykinin is a peptide corresponding to the primary component of the kallikrein-kinin system, which is involved in renal and cardiovascular processes that promote vasodilation and increase vascular permeability and is a mediator of the inflammatory cascade, contributing to the local pulmonary edema seen in COVID-19. This evidence concerns the gene KLK4 and COVID-19.